HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanchun Xu Selected Research

Lung Injury

10/2015Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanchun Xu Research Topics

Disease

5Vivax Malaria
11/2023 - 03/2021
4Malaria
11/2023 - 12/2018
2Acute Kidney Injury (Acute Renal Failure)
01/2023 - 01/2020
2Hypertrophy
08/2017 - 01/2017
2Myocardial Infarction
01/2017 - 01/2013
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2023
1Autoimmune Diseases (Autoimmune Disease)
04/2023
1Diabetes Mellitus
01/2023
1Urogenital Neoplasms
01/2023
1IGA Glomerulonephritis (IGA Nephropathy)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Atrophy
01/2022
1Heart Failure
01/2021
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Compression Fractures (Compression Fracture)
10/2020
1Hypoxia (Hypoxemia)
01/2020
1Ischemia
01/2020
1Microvascular Rarefaction
01/2020
1Necrosis
01/2020
1Infections
12/2019
1Falciparum Malaria (Plasmodium falciparum Malaria)
12/2018
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2018
1Neoplasms (Cancer)
01/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Cardiomegaly (Heart Hypertrophy)
08/2017
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2017
1Lung Injury
10/2015
1Acute Lung Injury
10/2015
1Stroke (Strokes)
01/2013
1Reperfusion Injury
01/2013

Drug/Important Bio-Agent (IBA)

4Chloroquine (Aralen)FDA LinkGeneric
11/2023 - 01/2021
3Antimalarials (Antimalarial Agents)IBA
06/2023 - 12/2018
2Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2019
2CreatinineIBA
01/2022 - 01/2020
2NitrogenIBA
01/2022 - 01/2020
2EnzymesIBA
11/2021 - 03/2021
2PrimaquineFDA Link
11/2021 - 03/2021
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2021 - 03/2021
2artemisinin (artemisinine)IBA
01/2021 - 12/2018
2CytokinesIBA
10/2020 - 10/2015
1Immunoglobulin D (IgD)IBA
04/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Angiotensin Receptor AntagonistsIBA
01/2023
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2023
1Proton Pump InhibitorsIBA
01/2023
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2023
1DiureticsIBA
01/2023
1HomocysteineIBA
01/2022
1Uric Acid (Urate)IBA
01/2022
1Therapeutic UsesIBA
03/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2021
1pro-brain natriuretic peptide (1-76)IBA
01/2021
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2021
1Pyrimethamine (Daraprim)FDA Link
01/2021
1Neprilysin (Neutral Endopeptidase)IBA
01/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021
118S Ribosomal RNAIBA
11/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
01/2020
1Histidine (L-Histidine)FDA Link
12/2019
1AMP-Activated Protein KinasesIBA
08/2017
1Adenosine Monophosphate (AMP)IBA
08/2017
1GlycogenIBA
08/2017
1CystathionineIBA
08/2017
1Sirolimus (Rapamycin)FDA Link
08/2017
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2015
1Hyaluronic Acid (Hyaluronan)IBA
10/2015
1ChemokinesIBA
10/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2013

Therapy/Procedure

4Therapeutics
01/2023 - 01/2018
1Peritoneal Dialysis
01/2021
1Kyphoplasty
10/2020
1Ligation
01/2013